Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up? | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

PostScript

Letter

Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?

Authors

Antonella Nappi HospitalPharmacy - Pharmacovigilance Unit, Ospedali dei Colli, P.O. D.Cotugno, Naples, Italy PubMed articles Google scholar articles
Alessandro Perrella VII Unit InfectiousDiseaseand Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy PubMed articles Google scholar articles
Luca Rinaldi Gastroenterology Unit, Università degli Studi della Campania "LuigiVanvitelli", Naples, italy PubMed articles Google scholar articles
Antonio Izzi AORN Ospedali dei Colli, Napoli, Italy PubMed articles Google scholar articles
Rodolfo Punzi AORN Ospedali dei Colli, Napoli, Italy PubMed articles Google scholar articles
Luigi Elio Adinolfi Gastroenterology Unit, Università degli Studi della Campania "LuigiVanvitelli", Naples, italy PubMed articles Google scholar articles
Costanza Sbeglia VII Unit InfectiousDiseaseand Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy PubMed articles Google scholar articles
Pasquale Bellopede VII Unit InfectiousDiseaseand Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy PubMed articles Google scholar articles
Adelaide Maddaloni VII Unit InfectiousDiseaseand Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy PubMed articles Google scholar articles
Nunzia Papa HospitalPharmacy - Pharmacovigilance Unit, Ospedali dei Colli, P.O. D.Cotugno, Naples, Italy PubMed articles Google scholar articles
Micaela Spatarella HospitalPharmacy - Pharmacovigilance Unit, Ospedali dei Colli, P.O. D.Cotugno, Naples, Italy PubMed articles Google scholar articles

Correspondence to Dr Antonella Nappi, AORN Ospedali dei Colli, P.O. D.Cotugno, Via Quagliariello 54, Naples, Italy; antonella.nappi{at}ospedalideicolli.it; Dr Alessandro Perrella; alessandro.perrella{at}ospedalideicolli.it

Citation

Nappi A, Perrella A, Rinaldi L, et al

Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?

European Journal of Hospital Pharmacy 2019;26:243-244.

Publication history

First published June 14, 2019.

Online issue publication

July 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2019. No commercial re-use. See rights and permissions. Published by BMJ.